Komori
Governance4553TOWA PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Matters Concerning Controlling Shareholders

The company reported the voting rights ownership status of 株式会社吉田事務所 and its relationship with the company, treating it as an other affiliated company. There have been no new transactions, and the company recognizes that its independence has been maintained.

Worth reading
59In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
45.75
Voting rights ownership ratio (%)
Wording
Conditional
How definitive the wording is.

Governance structure

Controlling shareholder
株式会社吉田事務所40.85%Voting rights

other affiliated company); voting rights ownership ratio: 40.85% directly owned, 4.90% included in the aggregate, for a total of 45.75%. Stock exchange or other financial instruments exchange on which the issued share certificates are listed: —

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Changes this time

The company reported matters concerning controlling shareholders and other related parties, but no changes from the previous report were stated.

Governance structure
ItemDetails
Controlling shareholder株式会社吉田事務所 (other affiliated company); voting rights ownership ratio: 40.85% directly owned, 4.90% included in the aggregate, for a total of 45.75%. Stock exchange or other financial instruments exchange on which the issued share certificates are listed: —
Changes this timeThe company reported matters concerning controlling shareholders and other related parties, but no changes from the previous report were stated.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report matters concerning 株式会社吉田事務所, an other affiliated company, based on applicable laws and regulations and the disclosure requirements for listed companies. As there are no transactions with the parent company or other related parties and no impact on business activities, the company recognizes that its independence has been maintained.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | TOWA PHARMACEUTICAL CO.,LTD. (4553) timely disclosure | Komori